IPP Bureau
PM lays foundation stone for National Institute for One Health in Nagpur
By IPP Bureau - December 12, 2022
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
Entod Pharmaceuticals to launch GLO division
By IPP Bureau - December 12, 2022
This one-of-a-kind ophthalmic subspecialty division is focused on the treatment of the eye condition glaucoma
GSK announces new global headquarters in central London
By IPP Bureau - December 12, 2022
Company to open new headquarters in 2024
Roche presents new data for Polivy in previously untreated diffuse large B-cell lymphoma at ASH 2022
By IPP Bureau - December 12, 2022
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
GSK’s new data underscore important responses with momelotinib for myelofibrosis patients
By IPP Bureau - December 12, 2022
48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
Global pacemakers market set to grow at 5.4% CAGR over next 3 years: GlobalData
By IPP Bureau - December 12, 2022
GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.
Govt to celebrate Universal Health Coverage Day 2022
By IPP Bureau - December 09, 2022
Anandiben Patel, Governor, Uttar Pradesh will inaugurate the two-day celebrations
World Ayurveda Congress and Arogya Expo 2022 inaugurated in Goa
By IPP Bureau - December 09, 2022
The 9th World Ayurveda Congress and Arogya Expo 2022 aims to showcase the efficacy and strength of the AYUSH systems of medicine at the global level
Emmes launches Cell and Gene Therapy Center
By IPP Bureau - December 09, 2022
The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies
Lupin appoints Spiro Gavaris as President of U.S. Generics Business
By IPP Bureau - December 09, 2022
Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business
Takeda’s dengue vaccine QDENGA approved for use in EU
By IPP Bureau - December 09, 2022
The approval follows the positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in October 2022
Samsung Engineering wins work contract from Sartorius for Korean plant
By IPP Bureau - December 09, 2022
The plant, to be built in the Incheon Free Economic Zone in Songdo, Incheon, will be a facility for the manufacture of products such as sterile bags, cell culture media and membrane filters
BASF and MedAccess complete shipment of 35 million interceptor G2 nets to fight malaria
By IPP Bureau - December 09, 2022
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
Ajooni Biotech Rs. 29.01 crore rights issue opens for subscription
By IPP Bureau - December 08, 2022
The funds raised through the issue will be utilised to meet the working capital requirements to fund the company's expansion plans, entering new geographies and for general corporate purposes
Aster DM Healthcare and Faruk Medical City to develop healthcare services in Iraq
By IPP Bureau - December 08, 2022
Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff
